Preview Mode Links will not work in preview mode

May 26, 2021

Proceedings from from the tenth in a series of 11 integrated webinars held in association with the 2021 ONS Annual Congress. Featuring perspectives from Drs Brian T Hill, John M Pagel and Jennifer Woyach on cases from the practices of Ms Lesley Camille Ballance, Ms Kristen E Battiato and Ms Corinne Hoffman, including the following topics:

  • Introduction (0:00)
  • Overview of the Current Era of Chronic Lymphocytic Leukemia (CLL) Treatment (5:37)
  • Up-Front Treatment of CLL with a BTK (Bruton Tyrosine Kinase) Inhibitor (10:24)
  • Case: A woman in her mid-70s with CLL who receives first-line ibrutinib — Kristen E Battiato, AGNP-C (10:34)
  • Case: A woman in her early 50s with previously untreated CLL who receives acalabrutinib — Lesley Camille Ballance, MSN, FNP-BC (34:17)
  • Up-Front Treatment with Obinutuzumab/Venetoclax (53:31)
  • Case: A man in his early 70s with CLL who desires time-limited therapy— Ms Battiato (53:55)
  • Case: A man in his late 60s with CLL and malignant pleural effusions — Corinne Hoffman, MS, APRN-CNP, AOCNP (1:02:33)
  • Case: A woman in her mid-40s with CLL who was initially observed off treatment — Ms Ballance (1:15:43)
  • Future Directions in CLL Therapy (1:17:30)

NCPD information and select publications